PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24803746-4	2014	The results showed that BHBA significantly reduced LPS-induced protein and mRNA expression levels of iNOS, COX-2, TNF-alpha, IL-1beta, and IL-6.	3-Hydroxybutyric Acid	24-28	tumor necrosis factor	Mus musculus	114-123	
31332890-5	2019	Pretreatment with BHB upregulated the level of tumor necrosis factor alpha and interleukin-6 in plasma, promoted the activities of caspase-3, caspase-8, and caspase-9 and increased the count of terminal deoxynucleotidyl transferase dUTP nick end labeling-positive cells.	3-Hydroxybutyric Acid	18-21	tumor necrosis factor	Mus musculus	47-74	
26116596-12	2015	Nitric oxide accumulation, induced by IFN-gamma/TNF-alpha, was inhibited by nicotinic acid and 3-hydroxy-butyrate.	3-Hydroxybutyric Acid	95-113	tumor necrosis factor	Mus musculus	48-57	
20684827-9	2010	In addition, aortic expression of proatherogenic molecules including TNF-alpha, IL-1beta, IL-6, MCP-1 and VCAM-1, was lower in the BHB-TZD group than the control group.	3-Hydroxybutyric Acid	131-134	tumor necrosis factor	Mus musculus	69-78	
34880753-8	2021	BHBA significantly improved water maze performance; increased the ACh content, SOD activity, and SIRT1 expression; and decreased AChE and LDH activity, ROS, MDA, IL-1beta, TNF-alpha contents, and NLRP3 expression.	3-Hydroxybutyric Acid	0-4	tumor necrosis factor	Mus musculus	172-181